Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
US8399493B2 · kind B2 · utility
48Cited by
19References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 16, 2005 |
| Grant date | Mar 19, 2013 |
| Priority date | — |
| Expiry date | Apr 26, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to methods for treating or controlling schizophrenia in a mammal using compounds having the Formula (I), wherein M1 and M2 are defined in the application.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.